Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany

被引:0
作者
Lisa Vetter
Monika Keller
Thomas Bruckner
Michael Golatta
Sabine Eismann
Christina Evers
Nicola Dikow
Christof Sohn
Jörg Heil
Sarah Schott
机构
[1] University Hospital Heidelberg,Department of Obstetrics and Gynecology
[2] University Hospital Heidelberg,Department of Psychosomatic, Internal Medicine
[3] University Hospital Heidelberg,Institute of Medical Biometry and Informatics
[4] Heidelberg University,Institute of Human Genetics
[5] German Cancer Research Center,DKTK
[6] DKFZ Heidelberg,undefined
来源
Breast Cancer Research and Treatment | 2016年 / 156卷
关键词
BRCA mutation; Adherence; Breast cancer; Compliance; Cancer surveillance program;
D O I
暂无
中图分类号
学科分类号
摘要
Breast cancer (BC) is the leading cancer among women worldwide and in 5–10 % of cases is of hereditary origin, mainly due to BRCA1/2 mutations. Therefore, the German Consortium for Familial Breast and Ovarian Cancer (HBOC) with its 15 specialized academic centers offers families at high risk for familial/hereditary cancer a multimodal breast cancer surveillance program (MBCS) with regular breast MRI, mammography, ultrasound, and palpation. So far, we know a lot about the psychological effects of genetic testing, but we know little about risk-correlated adherence to MBCS or prophylactic surgery over time. The aim of this study was to investigate counselees’ adherence to recommendations for MBCS in order to adjust the care supply and define predictors for incompliance. All counselees, who attended HBOC consultation at the University Hospital Heidelberg between July 01, 2009 and July 01, 2011 were eligible to participate. A tripartite questionnaire containing sociodemographic information, psychological parameters, behavioral questions, and medical data collection from the German consortium were used. A high participation rate was achieved among the study population, with 72 % returning the questionnaire. This study showed a rate of 59 % of full-adherers to the MBCS. Significant predictors for partial or full adherence were having children (p = 0.0221), younger daughters (p = 0.01795), a higher awareness of the topic HBOC (p = 0.01795, p < 0.0001), a higher perceived breast cancer risk (p < 0.0001), and worries (p = 0.0008)/impairment (p = 0.0257) by it. Although the current data suggest a good adherence of MBCS, prospective studies are needed to understand counselees’ needs to further improve surveillance programs and adherence to them. Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening—a monocenter study in Germany.
引用
收藏
页码:289 / 299
页数:10
相关论文
共 310 条
  • [1] Goldberg JI(2006)Breast cancer susceptibility testing: past, present and future Expert Rev Anticancer Ther 6 1205-1214
  • [2] Borgen PI(2013)Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE J Natl Cancer Inst 105 812-822
  • [3] Mavaddat N(1990)Linkage of early-onset familial breast cancer to chromosome 17q21 Science 250 1684-1689
  • [4] Peock S(1994)Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13 Science 265 2088-2090
  • [5] Frost D(2011)Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany J Commun Genet 2 53-69
  • [6] Ellis S(2014)Strukturiertes Mammakarzinom-Früherkennungsprogramm Der Gynäkologe 47 746-752
  • [7] Platte R(2013)Fünfzehn spezialisierte Zentren für Betroffene Mamma Mia! Das Brustkrebsmagazin 2 16-17
  • [8] Fineberg E(2013)Genetic counseling does not fulfill the counselees’ need for certainty in hereditary breast/ovarian cancer families: an explorative assessment Psycho-oncology 22 1167-1176
  • [9] Evans DG(2001)Psychological impact of receiving a BRCA1/BRCA2 test result Am J Med Genet 98 15-24
  • [10] Izatt L(2001)Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs—assessment survey CMAJ Can Med Assoc Journal 164 1005-1009